Table 2.

Associated factors with collateral circulation in acute ischemic stroke patients

	Poor (n = 43)	Moderate (n = 52)	Good (n = 25)	P value	Univariate logistic analysis
					Poor vs. not poor rLMC	Good vs. not good rLMC
Age > 60 years	30 (69.8)	40 (76.9)	15 (60.0)	0.269	0.85 (0.36–1.97)	0.54 (0.21–1.38)
Hypertension history	24 (55.8)	25 (48.1)	11 (44.0)	0.601	1.36 (0.61–3.07)	0.85 (0.33–2.21)
Diabetes	6 (13.9)	8 (15.4)	2 (8.0)	0.664	0.89 (0.28–2.80)	0.48 (0.09–2.44)
Atrial fibrillation	42 (97.7)	48 (92.3)	22 (88.0)	0.282	3.50 (0.38–32.55)	0.61 (0.13–2.97)
Coronary heart disease	9 (20.9)	8 (15.4)	0 (0.0)	0.023	1.46 (0.51–4.17)	–
Previous stroke	5 (11.6)	10 (19.2)	1 (4.00)	0.168	0.55 (0.17–1.76)	0.18 (0.02–1.45)
Systolic blood pressure	34.98 ± 19.98	137.77 ± 21.91	38.28 ± 16.43	0.74	0.99 (0.95–1.02)	1.02 (0.97–1.07)
Diastolic blood pressure	82.67 ± 16.53	80.54 ± 14.04	80.56 ± 14.78	0.761	1.00 (0.96–1.05)	0.93 (0.87–0.99)
Serum glucose	8.33 ± 2.63	7.44 ± 2.17	7.84 ± 2.41	0.252	1.12 (0.98–1.40)	1.09 (0.88–1.34)
Triglyceride	1.51 ± 1.40	1.48 ± 1.99	1.63 ± 0.95	0.106	1.01 (0.69–1.47)	1.06 (0.79–1.39)
Cholesterol	3.92 ± 0.84	3.79 ± 1.09	4.43 ± 0.86	0.173	1.18 (0.75–1.85)	1.83 (1.16–3.40)
HDL-C	1.36 ± 0.44	1.38 ± 0.64	1.44 ± 0.57	0.864	0.91 (0.43–1.94)	1.17 (0.52–2.63)
LDL-C	2.35 ± 0.74	2.04 ± 0.68	2.54 ± 0.67	0.008	1.33 (0.79–2.24)	1.99 (1.07–3.72)
Antihypertensive drugs	17 (39.5)	22 (42.3)	10 (40.0)	0.959	0.89 (0.39–2.03)	0.91 (0.34–2.40)
Antidiabetics	6 (13.9)	7 (13.5)	1 (4.00)	0.44	1.04 (0.32–3.37)	0.27 (0.03–2.31)
Antiplatelet drugs	5 (11.6)	11 (21.2)	5 (20.0)	0.449	0.49 (0.16–1.54)	0.93 (0.29–3.05)
Statins	3 (6.9)	13 (25.0)	5 (20.0)	0.068	0.33 (0.06–0.85)	1.23 (0.40–3.77)
Warfarin	5 (11.6)	15 (28.9)	9 (36.0)	0.045	0.21 (0.10–0.83)	2.11 (0.81–5.48)

HDL high density lipoprotein, LDL high density lipoprotein, CTA computer tomography angiography, ICA internal carotid artery, NIHSS National Institutes of Health Stroke Scale, LMC leptomeningeal collateral